Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-10-25
1990-09-11
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3138
Patent
active
049563815
ABSTRACT:
.alpha.-[10-oxy-4H-benzo[4,5]cycloheptal[1,2-b]thiophen-4-ylidene]-carboxyl ic acids, or physiologically-hydrolysable and -acceptable esters or pharmaceutically acceptable salts thereof are useful for effecting monokine inhibition, in particular interleukin-1 release or secretion inhibition, as a therapeutic means other than anti-inflammatory or anti-pyretic means.
REFERENCES:
patent: 4692460 (1987-09-01), Carson
Bollinger Pietro
Gubler Hans U.
Schnyder Jorg
Friedman Stanley J.
Honr Robert S.
McGovern Thomas O.
Sandoz Ltd.
Sharkin Gerald D.
LandOfFree
Treating tissue calcium depletion or degenerative processes in b does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treating tissue calcium depletion or degenerative processes in b, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treating tissue calcium depletion or degenerative processes in b will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1185083